Patient
SITE008-0052
completed Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE008 (KOR) (Dr. Kim)
consented 2025-10-28
Adverse events
7
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 7
Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-09-14 (study day 125); relationship: NOT RELATED
Grade 2 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2022-09-03 (study day 114); relationship: not assessed
Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-08-17 (study day 97); relationship: NOT RELATED
Grade 1 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-06-22 (study day 41); relationship: NOT RELATED
Grade 1 Nausea — outcome: UNKNOWN; onset 2022-06-16 (study day 35); relationship: not assessed
Grade 3 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-05-19 (study day 7); relationship: not assessed
Grade 1 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-05-14 (study day 2); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.